# Bitwave Semiconductor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bitwave-semiconductor

- Industry: Semiconductors
- Headquarters: Pepperell, US
- Website: www.bitwavesemiconductor.com
- Total disclosed funding: $23M
- Latest round: Series B (Aug 19, 2008)
- Investors on record: 3

## About

Bitwave Semiconductor specializes in the design and manufacture of Automated Test Equipment (ATE) tailored for semiconductor components, focusing on high-quality testing solutions for various industries including telecom, defense, automotive, and medical.Founded in 2003, Bitwave Semiconductor is based in Pepperell, US. The company develops Automated Test Equipment for semiconductor devices and serves a range of industries. The CEO, Mike Farese, leads the company, which has completed 4 deals since its inception, with the most recent being a Series C funding round on November 6, 2009, raising USD 1.3 million, which is also the total amount raised by the firm.Bitwave Semiconductor specializes in designing and manufacturing Automated Test Equipment (ATE) for semiconductor components. They provide custom ATE systems capable of testing up to 1,024 semiconductor devices simultaneously, featuring various testing capabilities such as burn-in testing, environmental stress testing, and functional testing, tailored to meet the stringent requirements of electronic devices in critical applications.The company generates revenue through B2B transactions with semiconductor manufacturers and government institutions by offering custom ATE solutions. Their revenue is enhanced by flagship products like ATE-Laser Test Systems and ATE-Photodiode Test Systems, critical for the telecommunications and defense sectors, enabling clients to achieve reliable product performance and streamlined operations.Bitwave Semiconductor plans to develop new ATE solutions designed to meet emerging market needs. The company is targeting expansion into North America and Asia, with specific markets identified for growth by 2025. The recent funding of USD 1.3 million raised in November 2009 will be utilized to support the development of these upcoming products and facilitate the expansion strategy.

## Funding rounds

- Series B, Aug 19, 2008, $10M — Apex Venture Partners, TVM Capital Life Science, ECentury Capital Partners
- Series A, Jan 1, 2004, $13M — Apex Venture Partners, TVM Capital Life Science, ECentury Capital Partners

## Investors

- Apex Venture Partners (https://capitalatlas.ai/funds/apex-venture-partners) — Series A, Series B
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A, Series B
- ECentury Capital Partners (https://capitalatlas.ai/funds/ecentury-capital-partners) — Series A, Series B